Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience

INTRODUCTION: Glucocorticoids (GC) are currently recommended as a bridging therapy in combination with conventional synthetic disease-modifying anti-rheumatic drugs (csDMARD) for the treatment of rheumatoid arthritis (RA) and should be tapered as rapidly as clinically feasible. We aimed to explore p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wenhui, Huang, Hong, Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011229/
https://www.ncbi.nlm.nih.gov/pubmed/36609980
http://dx.doi.org/10.1007/s40744-022-00527-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011229/
https://www.ncbi.nlm.nih.gov/pubmed/36609980
http://dx.doi.org/10.1007/s40744-022-00527-9

Ejemplares similares